
Michael J. Schmitt
Examiner (ID: 3933)
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629 |
| Total Applications | 811 |
| Issued Applications | 446 |
| Pending Applications | 73 |
| Abandoned Applications | 317 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19343520
[patent_doc_number] => 20240252483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => GASTRIC RESIDENCE SYSTEMS COMPRISING BUPRENORPHINE AND NALOXONE
[patent_app_type] => utility
[patent_app_number] => 18/289331
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40215
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -116
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289331
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/289331 | GASTRIC RESIDENCE SYSTEMS COMPRISING BUPRENORPHINE AND NALOXONE | May 3, 2022 | Pending |
Array
(
[id] => 19150119
[patent_doc_number] => 11975009
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => Use of zinc porphyrin as an antimicrobial
[patent_app_type] => utility
[patent_app_number] => 17/734581
[patent_app_country] => US
[patent_app_date] => 2022-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 34
[patent_no_of_words] => 19261
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17734581
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/734581 | Use of zinc porphyrin as an antimicrobial | May 1, 2022 | Issued |
Array
(
[id] => 17928271
[patent_doc_number] => 20220323396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION USING ANTIVIRAL COCKTAILS
[patent_app_type] => utility
[patent_app_number] => 17/712724
[patent_app_country] => US
[patent_app_date] => 2022-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15668
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17712724
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/712724 | COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION USING ANTIVIRAL COCKTAILS | Apr 3, 2022 | Abandoned |
Array
(
[id] => 17733261
[patent_doc_number] => 20220218720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => TREPROSTINIL ADMINISTRATION BY INHALATION
[patent_app_type] => utility
[patent_app_number] => 17/707651
[patent_app_country] => US
[patent_app_date] => 2022-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 233
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17707651
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/707651 | TREPROSTINIL ADMINISTRATION BY INHALATION | Mar 28, 2022 | Abandoned |
Array
(
[id] => 20341898
[patent_doc_number] => 12465613
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-11
[patent_title] => Pharmaceutical composition for use in the prophylactic and/or therapeutic treatment of L-DOPA-induced dyskinesia
[patent_app_type] => utility
[patent_app_number] => 17/701391
[patent_app_country] => US
[patent_app_date] => 2022-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 0
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17701391
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/701391 | Pharmaceutical composition for use in the prophylactic and/or therapeutic treatment of L-DOPA-induced dyskinesia | Mar 21, 2022 | Issued |
Array
(
[id] => 17733183
[patent_doc_number] => 20220218642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => Compositions And Methods For Prevention And Reduction Of Traumatic Brain Injury
[patent_app_type] => utility
[patent_app_number] => 17/696723
[patent_app_country] => US
[patent_app_date] => 2022-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6721
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17696723
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/696723 | Compositions and methods for prevention and reduction of traumatic brain injury | Mar 15, 2022 | Issued |
Array
(
[id] => 18282415
[patent_doc_number] => 20230097887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => Bi-functional Molecules to Degrade Circulating Proteins
[patent_app_type] => utility
[patent_app_number] => 17/695259
[patent_app_country] => US
[patent_app_date] => 2022-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32620
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17695259
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/695259 | Bi-functional Molecules to Degrade Circulating Proteins | Mar 14, 2022 | Pending |
Array
(
[id] => 18034538
[patent_doc_number] => 20220378753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => NOVEL INHIBITORS OF LYSYL OXIDASES
[patent_app_type] => utility
[patent_app_number] => 17/693371
[patent_app_country] => US
[patent_app_date] => 2022-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19394
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17693371
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/693371 | Inhibitors of lysyl oxidases | Mar 12, 2022 | Issued |
Array
(
[id] => 17850460
[patent_doc_number] => 20220280501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => USING GENO- OR PHENOTYPING TO ADJUST LSD DOSING
[patent_app_type] => utility
[patent_app_number] => 17/685138
[patent_app_country] => US
[patent_app_date] => 2022-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10130
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17685138
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/685138 | USING GENO- OR PHENOTYPING TO ADJUST LSD DOSING | Mar 1, 2022 | Pending |
Array
(
[id] => 19490510
[patent_doc_number] => 12109194
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-08
[patent_title] => Synergistic combination therapy for treating ALS
[patent_app_type] => utility
[patent_app_number] => 17/684279
[patent_app_country] => US
[patent_app_date] => 2022-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11190
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17684279
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/684279 | Synergistic combination therapy for treating ALS | Feb 28, 2022 | Issued |
Array
(
[id] => 17609778
[patent_doc_number] => 20220152057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/591808
[patent_app_country] => US
[patent_app_date] => 2022-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42242
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17591808
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/591808 | METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS | Feb 2, 2022 | Abandoned |
Array
(
[id] => 17609776
[patent_doc_number] => 20220152055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/591783
[patent_app_country] => US
[patent_app_date] => 2022-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42239
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17591783
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/591783 | METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS | Feb 2, 2022 | Abandoned |
Array
(
[id] => 17609774
[patent_doc_number] => 20220152053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/591727
[patent_app_country] => US
[patent_app_date] => 2022-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42184
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17591727
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/591727 | METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS | Feb 2, 2022 | Abandoned |
Array
(
[id] => 17609775
[patent_doc_number] => 20220152054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/591777
[patent_app_country] => US
[patent_app_date] => 2022-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17591777
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/591777 | METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS | Feb 2, 2022 | Abandoned |
Array
(
[id] => 17609773
[patent_doc_number] => 20220152052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/591724
[patent_app_country] => US
[patent_app_date] => 2022-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17591724
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/591724 | METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS | Feb 2, 2022 | Abandoned |
Array
(
[id] => 17609777
[patent_doc_number] => 20220152056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/591798
[patent_app_country] => US
[patent_app_date] => 2022-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41988
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17591798
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/591798 | METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS | Feb 2, 2022 | Abandoned |
Array
(
[id] => 17609779
[patent_doc_number] => 20220152058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/591813
[patent_app_country] => US
[patent_app_date] => 2022-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42158
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17591813
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/591813 | METHODS AND COMPOSITIONS FOR TREATING VARIOUS DISORDERS | Feb 2, 2022 | Abandoned |
Array
(
[id] => 17774879
[patent_doc_number] => 20220241228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => Treatment of cholangiopathies
[patent_app_type] => utility
[patent_app_number] => 17/588273
[patent_app_country] => US
[patent_app_date] => 2022-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6565
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588273
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/588273 | Treatment of cholangiopathies | Jan 28, 2022 | Pending |
Array
(
[id] => 17593388
[patent_doc_number] => 20220142961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => CCL5 Inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/580429
[patent_app_country] => US
[patent_app_date] => 2022-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17580429
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/580429 | CCL5 inhibitors | Jan 19, 2022 | Issued |
Array
(
[id] => 19032419
[patent_doc_number] => 20240082234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => APPLICATION OF CILOSTAZOL-CONTAINING COMPOSITION IN PREPARING DRUG FOR TREATING CEREBROVASCULAR DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/271991
[patent_app_country] => US
[patent_app_date] => 2022-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18271991
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/271991 | APPLICATION OF CILOSTAZOL-CONTAINING COMPOSITION IN PREPARING DRUG FOR TREATING CEREBROVASCULAR DISEASE | Jan 11, 2022 | Pending |